UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 116

Sortiert nach

Molecular consequences of dominant Bethlem myopathy collagen VI mutations

Annals of neurology, 2007-10, Vol.62 (4), p.390-405

2007

Volltextzugriff (PDF)

Collagen VI glycine mutations: Perturbed assembly and a spectrum of clinical severity

Annals of neurology, 2008-09, Vol.64 (3), p.294-303

2008

Volltextzugriff (PDF)

The C5 Domain of the Collagen VI alpha 3(VI) Chain Is Critical for Extracellular Microfibril Formation and Is Present in the Extracellular Matrix of Cultured Cells

The Journal of biological chemistry, 2006-06, Vol.281 (24), p.16607-16614

2006

Volltextzugriff (PDF)

Collagen VI Microfibril Formation Is Abolished by an α2(VI) von Willebrand Factor Type A Domain Mutation in a Patient with Ullrich Congenital Muscular Dystrophy

The Journal of biological chemistry, 2010-10, Vol.285 (43), p.33567-33576

2010

Volltextzugriff (PDF)

Recognition by medical and nursing professionals of malnutrition and risk of malnutrition in elderly hospitalised patients

Nutrition & dietetics, 2008-06, Vol.65 (2), p.144-150

2008

Volltextzugriff (PDF)

The C5 Domain of the Collagen VI α3(VI) Chain Is Critical for Extracellular Microfibril Formation and Is Present in the Extracellular Matrix of Cultured Cells

The Journal of biological chemistry, 2006-06, Vol.281 (24), p.16607-16614

2006

Volltextzugriff (PDF)

Collagen VI Microfibril Formation Is Abolished by an a2(VI) von Willebrand Factor Type A Domain Mutation in a Patient with Ullrich Congenital Muscular Dystrophy

The Journal of biological chemistry, 2010-10, Vol.285 (43), p.33567-33576

2010

Volltextzugriff (PDF)

Collagen VI Microfibril Formation Is Abolished by an alpha 2(VI) von Willebrand Factor Type A Domain Mutation in a Patient with Ullrich Congenital Muscular Dystrophy

The Journal of biological chemistry, 2010-10, Vol.285 (43), p.33567-33576

2010

Volltextzugriff (PDF)

Collagen VI mutations: A review of 54 patients

Matrix biology, 2008-12, Vol.27, p.53-54

2008

Volltextzugriff (PDF)

The C5 domain of the collagen VI alpha3(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells

The Journal of biological chemistry, 2006-06, Vol.281 (24), p.16607

2006

Volltextzugriff (PDF)

The C5 Domain of the Collagen VI Î±3(VI) Chain Is Critical for Extracellular Microfibril Formation and Is Present in the Extracellular Matrix of Cultured Cells

The Journal of biological chemistry, 2006-06, Vol.281 (24), p.16607

2006

Volltextzugriff (PDF)

Collagen VI microfibril formation is abolished by an {alpha}2(VI) von Willebrand factor type A domain mutation in a patient with Ullrich congenital muscular dystrophy

The Journal of biological chemistry, 2010-10, Vol.285 (43), p.33567-33576

2010

Volltextzugriff (PDF)

Attenuation of Chikungunya Virus Vaccine Strain 181/Clone 25 Is Determined by Two Amino Acid Substitutions in the E2 Envelope Glycoprotein

Journal of Virology, 2012-06, Vol.86 (11), p.6084-6096

2012

Volltextzugriff (PDF)

Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma

Journal of clinical oncology, 2013-01, Vol.31 (2), p.181-186

2013

Volltextzugriff (PDF)

The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

The Lancet (British edition), 2020-12, Vol.396 (10267), p.2019-2082

2020

Volltextzugriff (PDF)

Evolution and spread of Venezuelan equine encephalitis complex alphavirus in the Americas

PLoS neglected tropical diseases, 2017-08, Vol.11 (8), p.e0005693-e0005693

2017

Volltextzugriff (PDF)

Analysis of insulin glulisine at the molecular level by X-ray crystallography and biophysical techniques

Scientific reports, 2021-01, Vol.11 (1), p.1737-10, Article 1737

2021

Volltextzugriff (PDF)

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

The Lancet (British edition), 2016-02, Vol.387 (10019), p.661-670

2016

Volltextzugriff (PDF)

The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation

The Lancet infectious diseases, 2021-07, Vol.21 (7), p.962-974

2021

Volltextzugriff (PDF)

A novel live-attenuated vaccine candidate for mayaro Fever

PLoS neglected tropical diseases, 2014-08, Vol.8 (8), p.e2969-e2969

2014

Volltextzugriff (PDF)

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Annals of the rheumatic diseases, 2021-09, Vol.80 (9), p.1137

2021

Volltextzugriff (PDF)

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

The Lancet (British edition), 2021-01, Vol.397 (10269), p.99-111

2021

Volltextzugriff (PDF)

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

The Lancet (British edition), 2020-08, Vol.396 (10249), p.467-478

2020

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(116)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Life Sciences & Biomedicine
(73)
Humans
(69)
Female
(35)
Male
(34)
General & Internal Medicine
(25)
Covid-19
(23)
Adult
(22)
Middle Aged
(20)
Child
(18)
Medicine, General & Internal
(17)
Pediatrics
(15)
Adolescent
(14)
Coronaviruses
(14)
Severe Acute Respiratory Syndrome Coronavirus 2
(13)
Aged
(12)
Clinical Trials
(12)
Epidemics
(12)
Medicin Och Hälsovetenskap
(12)
Vaccines
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular consequences of dominant Bethlem myopathy collagen VI mutations

Collagen VI glycine mutations: Perturbed assembly and a spectrum of clinical severity

The C5 Domain of the Collagen VI alpha 3(VI) Chain Is Critical for Extracellular Microfibril Formation and Is Present in the Extracellular Matrix of Cultured Cells

Collagen VI Microfibril Formation Is Abolished by an α2(VI) von Willebrand Factor Type A Domain Mutation in a Patient with Ullrich Congenital Muscular Dystrophy

Recognition by medical and nursing professionals of malnutrition and risk of malnutrition in elderly hospitalised patients

The C5 Domain of the Collagen VI α3(VI) Chain Is Critical for Extracellular Microfibril Formation and Is Present in the Extracellular Matrix of Cultured Cells

Collagen VI Microfibril Formation Is Abolished by an a2(VI) von Willebrand Factor Type A Domain Mutation in a Patient with Ullrich Congenital Muscular Dystrophy

Collagen VI Microfibril Formation Is Abolished by an alpha 2(VI) von Willebrand Factor Type A Domain Mutation in a Patient with Ullrich Congenital Muscular Dystrophy

Collagen VI mutations: A review of 54 patients

The C5 domain of the collagen VI alpha3(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells

The C5 Domain of the Collagen VI Î±3(VI) Chain Is Critical for Extracellular Microfibril Formation and Is Present in the Extracellular Matrix of Cultured Cells

Collagen VI microfibril formation is abolished by an {alpha}2(VI) von Willebrand factor type A domain mutation in a patient with Ullrich congenital muscular dystrophy

Attenuation of Chikungunya Virus Vaccine Strain 181/Clone 25 Is Determined by Two Amino Acid Substitutions in the E2 Envelope Glycoprotein

Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma

The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

Evolution and spread of Venezuelan equine encephalitis complex alphavirus in the Americas

Monoclonal TCR-redirected tumor cell killing

Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2

Analysis of insulin glulisine at the molecular level by X-ray crystallography and biophysical techniques

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation

A novel live-attenuated vaccine candidate for mayaro Fever

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Suchergebnisse filtern